Thursday, February 2, 2012

Auxogyn Rounds Out Funding Round At $20M

Menlo Park-based Auxogyn, which is developing a system to improve invitro fertilization, said today that it has closed out its Series A round at $20M. According to the firm, the final tranche of its Series A included Kleiner Perkins Caufield and Byers, TPG Biotech and Merck Serono Ventures. Auxogyn is developing a non-invasive early embryo viability assessment, which is being applied to provide better success with IVF. More information »